Iodine-131 sodium iodide solution (for preparation of oral solution or capsules)
Approved Use: Treatment of hyperthyroidism and thyroid carcinomas that take up iodine
Brand Name: HICON®
Manufacturer: Jubilant Radiopharma
Package Insert
How Supplied:
Calibration:
Gelatin Capsule Blister Pack:
Kit Information
Old Formulation vs. New Formulation
Letter from Manufacturer August 2016 (appropriate use of blister packs)
Letter from Manufacturer February 2012 (new formulation - launch date)
Letter from Manufacturer December 2011 (new formulation approved)
Manufacturer: Jubilant Radiopharma
Package Insert
How Supplied:
- 250 mCi
- 500 mCi
- 1000 mCi
Calibration:
- Sunday 12:00 ET
- Monday 12:00 ET
- Saturday 12:00 ET
- 9 days after calibration date (14 days after manufacture date)
- Compounded capsule expires 7 days after preparation date
- *Solution expiry versus compounded capsule expiry*
Gelatin Capsule Blister Pack:
- Contains 10 (size #2) inner gel caps containing ~300mg dibasic sodium phosphate anhydrous USP
- Contains 10 (size #1) empty gelatin capsules
- Discard unused capsules after all HICON® has been dispensed
- 65174-880-25
- 65174-880-50
- 65174-880-00
Kit Information
Old Formulation vs. New Formulation
Letter from Manufacturer August 2016 (appropriate use of blister packs)
Letter from Manufacturer February 2012 (new formulation - launch date)
Letter from Manufacturer December 2011 (new formulation approved)
HICON® Availability Chart:
Ship Day |
Delivery Day |
Calibration Day |
Monday |
Tuesday |
Saturday |
Tuesday |
Wednesday |
Sunday |
Wednesday |
Thursday |
Monday |
Manufacturer: International Isotopes Inc.
Package Insert
How Supplied:
Calibration:
Expiration:
Availability:
Gelatin Capsule Blister Pack:
Package Insert
How Supplied:
- 1000 mCi
- 2000 mCi
- 3000 mCi
Calibration:
Expiration:
Availability:
Gelatin Capsule Blister Pack:
- Contains 10 (size #2) inner gel caps containing ~300mg dibasic sodium phosphate anhydrous USP
- Contains 10 (size #1) empty gelatin capsules
- 69208-001-15
- 69208-001-25
- 69208-001-35
Clinical Guidelines:
- ATA Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer (2015)
- ATA Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer (2015)
- SNMMI Procedure Standard for Therapy of Thyroid Disease with Iodine-131 (Sodium Iodide) 3.0 (2012)
- Radiation Safety in the Treatment of Patients with Thyroid Diseases by Radioiodine I-131: Practice Recommendations of the American Thyroid Association (2011)
- EANM Procedure Guidelines for Therapy of Benign Thyroid Disease (2010)
- EANM Guidelines for Radioiodine Therapy of Differentiated Thyroid Cancer (2008)